Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone.
Related Research units
Abstract
Development of FVIII inhibitors represents a major challenge in patients with mild haemophilia A (HA), because they tend to occur at an older age and classical immune tolerance induction appears to be less effective.
Bibliographical data
| Original language | English |
|---|---|
| ISSN | 0720-9355 |
| Publication status | Published - 2012 |
| pubmed | 22960877 |
|---|
